Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STOP-BPD hydrocortisone trial in ventilated preterm infants
NL-OMON26029Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in bronchopulmonary dysplasia (BPD) comparing Hydrocortisone with Placebo (2 arms). Primary endpoint: Survival free of bronchopulmonary dysplasia at 36 weeks postmenstrual age. Started Sep 2011; status: active, not recruiting.
02
Drugs
hydrocortisone
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NL-OMON26029.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26029.